Explanatory note
(This note is not part of the Regulations)
These Regulations further amend the Medicines (Sale or Supply) (Miscellaneous Provisions) Regulations 1980. The Regulations—
in relation to medicinal products on a general sale list containing bisacodyl, increase the maximum pack size in which such products may be sold or supplied from outlets other than registered pharmacies from 10 tablets to 20 tablets;
provide that medicinal products containing famotidine and which are on a general sale list may be sold or supplied from outlets other than registered pharmacies only in separate and individual containers or packages containing not more than 12 tablets;
provide that medicinal products containing heparinoid and which are on a general sale list may be sold or supplied from outlets other than registered pharmacies only in separate and individual containers or packages containing not more than 20 grams of the product.
An assessment of the cost to business of complying with these Regulations has been made, copies of which have been placed in the libraries of both Houses of Parliament. Further copies may be obtained from the Department of Health, Medicines Control Agency, Information Centre, Room 10–202, Market Towers, 1 Nine Elms Lane, London SW8 5NQ.